GemmaActon 211.9 in a local. And Brisbane and goldcost are cheaper.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US facing major oil price rise after production cutEnergy organisation OPEC has agreed to the biggest cut in oil production since before the pandemic. Sky News Washington Correspondent Annelise Nielsen says OPEC has justified this decision by saying it's necessary to try to curb global increases in prices. The countries in OPEC represent about 40 per cent of oil production globally. OPEC has decided to cut oil production by around two million barrels per day in November, with much of it being taken out of Russian production. Just another reminder the aim of capitalism is for producers to maximise profits and NOT contrary to the teachings of some corrupted media outlet for the benefit of us all
Source: SkyNewsAust - 🏆 7. / 78 Read more »
Fears grow over oil price as Opec+ agrees to bigger than expected output cutsCartel curbs production by 2m barrels a day despite strong US pressure, further squeezing supplies US price control. Oil and the $US Sanctions against Russia are backfiring on US control of the global market.
Source: GuardianAus - 🏆 1. / 98 Read more »
ASX closes little changed as OPEC output cut fuels energy rallyThe S&P/ASX 200 added 1.8 points on Thursday, boosted by a 2.2 per cent advance by the energy sector which benefited from higher oil prices.
Source: FinancialReview - 🏆 2. / 90 Read more »
Blood biotech Aegros chases $300m-plus float, raising firstBlood plasma biotech Aegros has mapped out plans for $300 million-plus listing on the ASX boards next year, in a bid to lure investors into two nera term private funding rounds.
Source: FinancialReview - 🏆 2. / 90 Read more »
Blood bitoech Aegros chases $300m-plus float, raising firstBlood plasma biotech Aegros has mapped out plans for $300 million-plus listing on the ASX boards next year, in a bid to lure investors into two nera term private funding rounds.
Source: FinancialReview - 🏆 2. / 90 Read more »